☰

Roxana M. Coman, Ph.D. - Publications

Affiliations: 
2007 University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Microbiology Biology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mavian C, Coman RM, Zhang X, Pomeroy S, Ostrov DA, Dunn BM, Sleasman JW, Goodenow MM. Molecular Docking-Based Screening for Novel Inhibitors of the Human Immunodeficiency Virus Type 1 Protease that Effectively Reduce the Viral Replication in Human Cells. Journal of Aids & Clinical Research. 12. PMID 34950525  0.562
2010 Robbins AH, Coman RM, Bracho-Sanchez E, Fernandez MA, Gilliland CT, Li M, Agbandje-McKenna M, Wlodawer A, Dunn BM, McKenna R. Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes. Acta Crystallographica. Section D, Biological Crystallography. 66: 233-42. PMID 20179334 DOI: 10.1107/S0907444909054298  0.566
2009 Ho SK, Perez EE, Rose SL, Coman RM, Lowe AC, Hou W, Ma C, Lawrence RM, Dunn BM, Sleasman JW, Goodenow MM. Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor. Aids (London, England). 23: 1631-40. PMID 19625947 DOI: 10.1097/Qad.0B013E32832E0599  0.563
2008 Ho SK, Coman RM, Bunger JC, Rose SL, O'Brien P, Munoz I, Dunn BM, Sleasman JW, Goodenow MM. Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. Virology. 378: 272-81. PMID 18599104 DOI: 10.1016/J.Virol.2008.05.029  0.565
2008 Coman RM, Robbins AH, Goodenow MM, Dunn BM, McKenna R. High-resolution structure of unbound human immunodeficiency virus 1 subtype C protease: implications of flap dynamics and drug resistance. Acta Crystallographica. Section D, Biological Crystallography. 754-63. PMID 18566511 DOI: 10.1107/S090744490801278X  0.582
2008 Coman RM, Robbins AH, Fernandez MA, Gilliland CT, Sochet AA, Goodenow MM, McKenna R, Dunn BM. The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease. Biochemistry. 47: 731-43. PMID 18092815 DOI: 10.1021/Bi7018332  0.588
2007 Coman RM, Robbins A, Goodenow MM, McKenna R, Dunn BM. Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 63: 320-3. PMID 17401206 DOI: 10.1107/S174430910701161X  0.586
2006 Clemente JC, Coman RM, Thiaville MM, Janka LK, Jeung JA, Nukoolkarn S, Govindasamy L, Agbandje-McKenna M, McKenna R, Leelamanit W, Goodenow MM, Dunn BM. Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir. Biochemistry. 45: 5468-77. PMID 16634628 DOI: 10.1021/Bi051886S  0.621
Show low-probability matches.